Strata Critical Medical, Inc.
corporate_fare Company Profile
Strata Critical Medical, Inc. (NASDAQ:SRTA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 16 items for SRTA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-04, rated 8/10. Across its 16 most recent items scored 7 or higher, the top rating is 8/10, with 10 rated 8 or above. Recent SEC coverage for SRTA spans 10-Q, 8-K, SCHEDULE 13D/A, DEF 14A.
Recent high-impact activity:
- Strata Critical Medical Lifts Full-Year Outlook as Q2 Revenue Jumps 61%
- Strata Critical Medical Lifts 2026 Outlook After 61% Revenue Jump in Q2
- Strata Critical Medical Lifts 2026 EBITDA Outlook to $33M-$35M
- Strata Critical Medical Q2 Revenue Seen Falling 5.3%, Missing Own Guidance
- Strata Acquires National Heart & Lung Transplant Program, Bolstering Organ Recovery Platform
Financial Snapshot
Short Interest & Short Volume
5.16 days to coverFINRA reported short interest of 4,358,719 shares in SRTA as of the September 15, 2026 settlement, a 3.7% decrease from the prior period — about 5.2 days to cover at its recent average daily volume. On October 2, 2026, 63.6% of SRTA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.